Charles Jones, DM, MRCP (he/him/his)

Hemay Pharmaceuticals
Naples, FL, United States

Charles Richard Jones, DM, MRCP, Global Medical Officer Hemay International.Thirty years of experience in clinical research and product development in global pharmaceutical biotech and CRO companies like InVentiv, Quintiles, J&J, Roche, Syntaxin, Aspreva and Syngenta. UK GMC registered and currently licensed practising physician. Over 80 publications in peer-reviewed scientific journals focused on translational medicine—a passion for bringing medicines to patients that change lives.

Presentation(s):

• 1124: A Double-blind, Placebo-parallel Controlled Phase III Clinical Study of the Efficacy and Safety of Hemay005 Tablets in Patients with Moderate to Severe Chronic Plaque Psoriasis in China

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2519: A Phase II Clinical Study to Investigate the Efficacy and Safety of Hemay005 Tablets in Patients with Active Behçet`sDisease

  Tuesday, November 14, 2023
  5:00 PM – 5:10 PM PT

  Disclosure information not submitted.